Dr. Stephen Robbins has been appointed Director of the Lady Davis Institute, effective January 2021.
Extensive growth was among the most notable features in the term of Dr. Samuel O. Freedman, who served as Director of the Lady Davis Institute from 1991 to 2000. Under his stewardship, the LDI emerged as one of Quebec’s premier medical research facilities.
In 1969, the Lady Davis Institute opened at the JGH and went on to become one of Quebec’s leading facilities for medical research.
In 2005, the world adopted the Montreal Cognitive Assessment, a simple, yet refined, questionnaire that had been developed by Dr. Howard Chertkow, founding director of the JGH Memory Clinic.
Testing and research into HIV/AIDS took a major step forward in June 2007 with the inauguration of a $5 million HIV/AIDS Bio-containment Laboratory whose development was spearheaded by research pioneer Dr. Mark Wainberg.
Bram Freedman has become the new President and CEO of the JGH Foundation, making him the third generation of his family to include the JGH a key element in his career.
To enable advanced cancer patients to cope with difficulties at the end of life, JGH researchers hope to develop better psychological support through an intervention that helps individuals find meaning in their radically altered lives.
Researchers in the Lady Davis Institute are among investigators from across Canada who will share in new federal funding of $2.5 million for research into various types of dementia, including Alzheimer’s disease.
The largest study ever conducted on the genetics of common, age-related bone disease has resulted in the identification of 153 new gene variants associated with the loss of bone mineral density, the strongest clinical risk factor for osteoporosis and a frequent cause of fractures.
Dr. Pierre Pluye, a Senior Investigator in the Centre for Clinical Epidemiology and Community Studies at the Lady Davis Institute, has been named 2017 Family Medicine Researcher of the Year by the College of Family Physicians of Canada.